New CFS Research from the CDC
Merits Director's Help to Attract Press
A special issue of the peer-reviewed journal
Pharmacogenomics features 14 papers about chronic fatigue syndrome
(CFS). The series of reports is based on the Centers for Disease Control and
Prevention's CFS Computational Challenge (referred to as C3), a unique effort to
bring diverse perspectives to the analysis of a huge data set based on numerous
evaluations of 227 CFS patients and controls. Twenty researchers applied cutting
edge techniques in medicine, genomics, engineering, computer science, physics
and other disciplines. They link CFS to high allostatic load and genes related
to the glucocortocoid receptor and sympathetic nervous system activity.
CDC plans an April 20 press event to draw attention to the
Challenge, the findings and the new insights into CFS gained through the effort.
CDC Director Dr. Julie Gerberding, along with principal investigator for CFS
research Dr. William Reeves and C3 innovator Dr. Suzanne Vernon, are scheduled
to be available to media.
The CFIDS Association of America
participated in the planning for C3 and co-sponsored the September 2005 meeting
at Cold Spring Harbor Laboratory, where the four teams presented their